NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Encora Therapeutics

Encora Therapeutics

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://encoratherapeutics.com/

Last Round

Seed

Sep 30, 2020

Total Funding Raised

$1.5M

Company Overview

Encora Therapeutics is a medical device company that develops non-invasive, wearable neuromodulation technology to provide on-demand relief for hand tremors in patients with conditions such as Essential Tremor and Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

neuromodulationwearable medical deviceessential tremor treatmentParkinson's diseasedigital therapeuticsvibrotactile stimulationnon-invasive therapyclosed-loop stimulationmedtechtremor managementbioelectronic medicinehealth IoTFDA-cleared deviceremote patient monitoringRPM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Encora Therapeutics Comparables

Compare Encora Therapeutics with similar companies based on industry and business-model similarity.

Encora Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allevion Therapeutics
89%
Fasikl, Inc.
86%
Cala Health
84%

Encora Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 30, 2020

Key People

Founding team and executive leadership

Nadim Yared

Chairman And CEO

Executive Team

Encora Therapeutics Investors

Notable investors and investment history

Encora Therapeutics investors
InvestorRounds
Good Growth CapitalSeed
Engine VenturesSeed
InnoSpark VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2025

    Presented research at the AAN 2025 Annual Meeting, receiving an award for its abstract.

  • Apr 14, 2025

    Received 'Abstract of Distinction' from the American Academy of Neurology.

Encora Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Encora Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Encora Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range20
Year Founded2019
Last FundingSep 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.